No red flags yet in swine flu vaccine tests

(AP) -- Health officials say their count of U.S. swine flu cases has surpassed 40,000, and deaths have risen to 263.

(AP) -- A U.S. health official said a swine flu vaccine could be available as early as October, but only if vaccine production and testing run smoothly this summer.

(AP) -- Drugmaker GlaxoSmithKline says it has started testing its swine flu vaccine in humans.

(AP) -- The number of confirmed swine flu cases in the United States has jumped to 64, federal officials said Tuesday, and states reported at least four more.

(AP) -- Get ready to roll up your sleeve three times for flu shots this fall. That's right, three times. This year's flu season is shaping up to be a very different one. Most people will need one shot for the regular seasonal ...

(AP) -- As many as 1 million Americans now have swine flu, U.S. health officials said Thursday, adding that 6 percent or more of some urban areas are infected. The estimate voiced by a government flu scientist ...

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...